tiprankstipranks
Unity Biotechnology announces new research on potential of Senolytics
PremiumThe FlyUnity Biotechnology announces new research on potential of Senolytics
3M ago
New Publication in Nature Medicine Supports Therapeutic Potential of Senolytics to Provide Long-lasting, Disease-modifying Intervention in Vision Loss
PremiumPress Releases
New Publication in Nature Medicine Supports Therapeutic Potential of Senolytics to Provide Long-lasting, Disease-modifying Intervention in Vision Loss
3M ago
Unity Biotechnology doses first patients in Phase 2 ASPIRE study of UBX1325
PremiumThe Fly
Unity Biotechnology doses first patients in Phase 2 ASPIRE study of UBX1325
5M ago
UNITY Biotechnology, Inc. Reports Third Quarter 2023 Financial Results and Business Updates
PremiumPress ReleasesUNITY Biotechnology, Inc. Reports Third Quarter 2023 Financial Results and Business Updates
5M ago
Unity Biotechnology announces exercise of warrants for $4.8M
PremiumThe Fly
Unity Biotechnology announces exercise of warrants for $4.8M
6M ago
UNITY Biotechnology Announces 48-Week Results from Phase 2 ENVISION Study of UBX1325 in Patients with Wet Age-Related Macular Degeneration
PremiumPress Releases
UNITY Biotechnology Announces 48-Week Results from Phase 2 ENVISION Study of UBX1325 in Patients with Wet Age-Related Macular Degeneration
7M ago
Unity Biotechnology downgraded to Neutral at Wedbush on limited cash runway
PremiumThe FlyUnity Biotechnology downgraded to Neutral at Wedbush on limited cash runway
10M ago
Unity Biotechnology downgraded to Neutral from Outperform at Wedbush
PremiumThe Fly
Unity Biotechnology downgraded to Neutral from Outperform at Wedbush
10M ago
Unity Biotechnology announces design of Phase 2b ASPIRE trial
PremiumThe Fly
Unity Biotechnology announces design of Phase 2b ASPIRE trial
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100